Skip to main content
OpenTrials
Completed

NCT Number: NCT03255551

Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure

Blood Pressure Lowering Effects of Amosartan Regarding Proviso in Patients with Hypertension

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

After taking Amozatan (AMS, amlodipine / rozanthin combination) in patients with essential hypertension, the percentage of patients who reached the mean systolic target blood pressure was evaluated

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with essential hypertension whose blood pressure is not adequately controlled by amlodipine or rosartan monotherapy
  • In patients with stage 2 hypertension (SBP 160-179 mmHg), patients requiring a combination therapy to reach the target blood pressure
  • Patients who were changed to amosartan while using other hypertensive agents

Exclusion criteria

  • Patients with hypersensitivity to dihydropyridine derivatives of amosartan
  • Women who are pregnant or who may be pregnant and breastfeeding
  • Patients with severe hepatic dysfunction
  • Patients with severe aortic stenosis
  • Patients at risk of shock
  • Patients participating in other clinical studies

Treatment and study plan

Amosartan

Drug

amosartan is a combination of amlodipine, which is a calcium channel blocker (CCB), and rozatan, an angiotensin II receptor antagonist (ARB), and is an antihypertensive agent

Primary outcomes

  1. Patients with essential hypertension evaluated the mean blood pressure after taking amosartan.

    Time frame: 6 month

    Blood Pressure Lowering Effects of Amosartan Regarding Proviso in Patients with Hypertension

Sponsors and collaborators

Lead sponsor

Seoul National University Bundang Hospital

Other

Registry information

Official study title

Blood Pressure Lowering Effects of Amosartan Regarding Proviso in Patients With Hypertension: Prospective, Multicenter, Observational Study

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Aug 21, 2017
Registry last updated
Aug 21, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.